Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 3, Pages 719
Publisher
MDPI AG
Online
2020-03-19
DOI
10.3390/cells9030719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of Collective Invasion in Ovarian Cancer
- (2019) Laura Moffitt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
- (2019) Saul Eugene Rivkin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine
- (2019) Stephanie Lheureux et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24.
- (2019) Mansoor Raza Mirza et al. JOURNAL OF CLINICAL ONCOLOGY
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
- (2019) Durga Khandekar et al. Frontiers in Oncology
- Oral metronomic cyclophosphamide in advanced ovarian cancer
- (2019) Michela Villa et al. ANTI-CANCER DRUGS
- Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary
- (2019) Matthew Dean et al. Cancers
- The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
- (2019) Roberts et al. Cancers
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
- (2019) Youngjin Han et al. ONCOGENE
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- Kinase Inhibitors and Ovarian Cancer
- (2019) Katopodis et al. Cancers
- Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
- (2019) Maree Bilandzic et al. Cancers
- Linking stemness with colorectal cancer initiation, progression, and therapy
- (2019) Deepak Narayanan Iyer et al. World Journal of Stem Cells
- Paclitaxel-Loaded Self-Assembled Lipid Nanoparticles as Targeted Drug Delivery Systems for the Treatment of Aggressive Ovarian Cancer
- (2018) Jiali Zhai et al. ACS Applied Materials & Interfaces
- Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
- (2018) Prakash P. Praharaj et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
- (2018) Suk Hyung Lee et al. CELL
- Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
- (2018) Ming Luo et al. Cell Metabolism
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
- (2018) Kathleen N Moore et al. Future Oncology
- Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis
- (2018) Tamsin R M Lannagan et al. GUT
- Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
- (2018) Amit M Oza et al. LANCET ONCOLOGY
- Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
- (2018) Michael Friedlander et al. LANCET ONCOLOGY
- Toxicity of Doxorubicin (Dox) to different experimental organ systems
- (2018) Arivalagan Pugazhendhi et al. LIFE SCIENCES
- PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
- (2018) Angela Russo et al. ONCOGENE
- Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability
- (2018) Alexandra R. Hyler et al. PLoS One
- Prognostic factors in epithelial ovarian cancer: A population-based study
- (2018) Lin-Chau Chang et al. PLoS One
- Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
- (2018) John K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Patient-derived tumor organoids for prediction of cancer treatment response
- (2018) Peter W. Nagle et al. SEMINARS IN CANCER BIOLOGY
- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
- (2018) Emily Chan et al. Oncotarget
- Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
- (2018) Christina Wefers et al. Frontiers in Immunology
- Cancer Stem Cell Metabolism and Potential Therapeutic Targets
- (2018) Vusala Snyder et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
- (2018) Krijn K. Dijkstra et al. CELL
- Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids
- (2018) Sarah J. Hill et al. Cancer Discovery
- Tumor immunotherapy—the potential of epigenetic drugs to overcome resistance
- (2018) Camilla M. Grunewald et al. Translational Cancer Research
- Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
- (2018) Maureen L. Drakes et al. Cancers
- Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
- (2018) Lynn Roy et al. Cancers
- Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled
- (2018) Yuliya Klymenko et al. Cancers
- Targeting the Microenvironment in High Grade Serous Ovarian Cancer
- (2018) Nkechiyere Nwani et al. Cancers
- Magmas inhibition as a potential treatment strategy in malignant glioma
- (2018) Kaijun Di et al. JOURNAL OF NEURO-ONCOLOGY
- PARP inhibition induces enrichment of DNA repair proficient CD133 and CD117 positive ovarian cancer stem cells
- (2018) Chiara Bellio et al. MOLECULAR CANCER RESEARCH
- Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
- (2018) Nuzhat Ahmed et al. SEMINARS IN CANCER BIOLOGY
- Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
- (2018) Awad Jarrar et al. STEM CELLS
- Engineering Precision Medicine
- (2018) Wujin Sun et al. Advanced Science
- Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
- (2018) Maria Barbolina Cancers
- Cell Origins of High-Grade Serous Ovarian Cancer
- (2018) Jaeyeon Kim et al. Cancers
- Patient-derived organoids: a promising model for personalized cancer treatment
- (2018) Huayu Yang et al. Gastroenterology Report
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
- (2017) S.B. Coburn et al. INTERNATIONAL JOURNAL OF CANCER
- A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
- (2017) Irina Kareva INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
- (2017) Kathleen N. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
- (2017) Julia Jabs et al. Molecular Systems Biology
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
- (2017) Jarno Drost et al. SCIENCE
- Epigenetics in ovarian cancer
- (2017) Yanina Natanzon et al. SEMINARS IN CANCER BIOLOGY
- Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer
- (2017) Masakazu Sato et al. Oncology Letters
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- (2017) et al. JAMA Oncology
- 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recurrent Disease
- (2016) M. K. Wilson et al. ANNALS OF ONCOLOGY
- A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
- (2016) Christopher G. Hubert et al. CANCER RESEARCH
- Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
- (2016) Phillip P. Santoiemma et al. GYNECOLOGIC ONCOLOGY
- Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges
- (2016) Karolina Okła et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
- (2016) Tze-Sian Chan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vitroandin vivocorrelates of physiological and neoplastic human Fallopian tube stem cells
- (2016) Yusuke Yamamoto et al. JOURNAL OF PATHOLOGY
- Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
- (2016) Jonathan A Ledermann et al. LANCET ONCOLOGY
- Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
- (2016) Yu Matsumoto et al. Nature Nanotechnology
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression
- (2016) H. Chkourko Gusky et al. Obesity Reviews
- New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination
- (2016) Lan G. Coffman et al. Translational Research
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
- (2016) Nuzhat Ahmed et al. Scientific Reports
- Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
- (2015) Irina Kareva et al. CANCER LETTERS
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Two Types of Ovarian Cortical Inclusion Cysts
- (2015) Natalie Banet et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
- (2015) A. Goodspeed et al. MOLECULAR CANCER RESEARCH
- Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
- (2015) Mami Matano et al. NATURE MEDICINE
- The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids
- (2015) Mirjana Kessler et al. Nature Communications
- LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
- (2015) Ruea-Yea Huang et al. Oncotarget
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Distinct Patterns of Structural and Numerical Chromosomal Instability Characterize Sporadic Ovarian Cancer
- (2015) Jane Bayani et al. NEOPLASIA
- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
- (2014) HaiXia Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- Cancer Cell Lines for Drug Discovery and Development
- (2014) J. L. Wilding et al. CANCER RESEARCH
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Ovarian tumor-initiating cells display a flexible metabolism
- (2014) Angela S. Anderson et al. EXPERIMENTAL CELL RESEARCH
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: A Meta-Analysis
- (2014) J. Cai et al. ONCOLOGIST
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- Magmas functions as a ROS regulator and provides cytoprotection against oxidative stress-mediated damages
- (2014) S Srivastava et al. Cell Death & Disease
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- The Impairment of MAGMAS Function in Human Is Responsible for a Severe Skeletal Dysplasia
- (2014) Cybel Mehawej et al. PLoS Genetics
- Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
- (2014) Masafumi Koshiyama et al. Biomed Research International
- Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
- (2014) Jennifer M. Cole et al. Jove-Journal of Visualized Experiments
- Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
- (2014) Khalid Abubaker et al. Frontiers in Oncology
- Milky Spots Promote Ovarian Cancer Metastatic Colonization of Peritoneal Adipose in Experimental Models
- (2013) Robert Clark et al. AMERICAN JOURNAL OF PATHOLOGY
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
- (2013) M Venere et al. CELL DEATH AND DIFFERENTIATION
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma
- (2013) K. Bahar-Shany et al. GYNECOLOGIC ONCOLOGY
- The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae
- (2013) Nelly Auersperg INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Cancer Development, Progression, and Therapy: An Epigenetic Overview
- (2013) Sibaji Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
- (2013) Nuzhat Ahmed et al. MOLECULAR ASPECTS OF MEDICINE
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Correction: Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines
- (2013) Federico Tagliati et al. PLoS One
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Ovarian Tumor Attachment, Invasion, and Vascularization Reflect Unique Microenvironments in the Peritoneum: Insights from Xenograft and Mathematical Models
- (2013) Mara P. Steinkamp et al. Frontiers in Oncology
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis
- (2012) A. Serafino et al. CURRENT CANCER DRUG TARGETS
- Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
- (2012) Nuzhat Ahmed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
- (2012) A. D. Steg et al. MOLECULAR CANCER THERAPEUTICS
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units
- (2012) C. J. Saunders et al. Science Translational Medicine
- Design, synthesis, and biological activity of novel Magmas inhibitors
- (2011) Paul T. Jubinsky et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
- (2011) C. Visus et al. CLINICAL CANCER RESEARCH
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
- (2011) Ilona Kryczek et al. INTERNATIONAL JOURNAL OF CANCER
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
- (2011) Neeraj Lalwani et al. RADIOGRAPHICS
- Detection, Characterization, and Spontaneous Differentiation In Vitro of Very Small Embryonic-Like Putative Stem Cells in Adult Mammalian Ovary
- (2011) Seema Parte et al. STEM CELLS AND DEVELOPMENT
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
- (2010) Aliza L. Leizer et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- In vitro metastatic colonization of human ovarian cancer cells to the omentum
- (2010) Shaheena M. Khan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
- (2010) Kazuhiko Ino CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli
- (2010) Federico Tagliati et al. ENDOCRINOLOGY
- Role of Magmas in protein transport and human mitochondria biogenesis
- (2010) D. Sinha et al. HUMAN MOLECULAR GENETICS
- The Origin of Ovarian Carcinomas
- (2010) Nelly Auersperg INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Natural immunity to pluripotency antigen OCT4 in humans
- (2010) K. M. Dhodapkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microenvironment and Pathogenesis of Epithelial Ovarian Cancer
- (2010) Antonio F. Saad et al. Hormones & Cancer
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
- (2009) N. M. Moss et al. CANCER RESEARCH
- Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer
- (2009) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
- Pathogenesis of Ovarian Cancer
- (2009) Robert J. Kurman et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
- (2009) Zachary T. Schafer et al. NATURE
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
- (2009) Andrew E. Teschendorff et al. PLoS One
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
- (2008) George S Watts et al. BMC Medical Genomics
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
- Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes
- (2008) Irma Virant-Klun et al. DIFFERENTIATION
- Folate receptor alpha as a tumor target in epithelial ovarian cancer
- (2008) Kimberly R. Kalli et al. GYNECOLOGIC ONCOLOGY
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics
- (2008) P. P. Szotek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parthenogenetic Embryo-Like Structures in the Human Ovarian Surface Epithelium Cell Culture in Postmenopausal Women with No Naturally Present Follicles and Oocytes
- (2008) Irma Virant-Klun et al. STEM CELLS AND DEVELOPMENT
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started